Back to search

Sweden· SE-20021217000199

Glukosamin MIP 400 mg Filmdragerad tablett

A medicinal product containing glukosamin, registered in Sweden by MIP Pharma GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedGlukosamin MIP 400 mg Filmdragerad ta…ATC—REGISTER NO.SE-20021217000199PACKS LISTED1CHECKEDAugust 27, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Glukosamin
Manufacturer
MIP Pharma GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
August 27, 2026

Packs & prices · 1

  • se_varunummer
    20021217000199

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glukosamin in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glukosamin products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Cyprus · Donarthril
  • Czechia · Artaxin, Flexove
  • Germany · Glucosamin Doppelherzpharma
  • Spain · Acenam, Duartron
  • Finland · Glucosamin Orion
  • France · Flexea, Osaflexan
  • United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
  • Greece · Donarot, Energorot
  • Hungary · Cartilamin, Glukozamin Pharma Nord
  • Ireland · Arthrimel, Dona
  • Iceland · Glucomed
  • Norway · Glucosamin Orifarm, Samin
  • Poland · Flexove
  • Portugal · Biartril, Glucomed
  • Slovakia · Glucomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d244818e-99df-4de4-b5e5-9a9e728eb5de
GET /v1/drugs/d244818e-99df-4de4-b5e5-9a9e728eb5de?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20021217000199",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20021217000199",
  "product_doc_link": "https://docetp.mpa.se/LMF/Glukosamin%20MIP%20400%20mg%20film-coated%20tablet%20ENG%20PL_09001bee807a3ddd.pdf"
}

See everything about glukosamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.